| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.33 | 3e-08 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |